Founders Financial Alliance’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-53
Closed -$5K 600
2020
Q3
$5K Buy
+53
New +$5K ﹤0.01% 955